EVOTAZ 300 MG/150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

USDailyMed:Atazanavir_and_cobicistat J05AR15(WHO) UK:POM(Prescription only)US:℞-onlyEU:Rx-only 2446322-19-4 D10753 Atazanavir/cobicistat(ATV/c), sold under the brand nameEvotaz, is afixed-dose combinationantiretroviral medicationused to treat and preventHIV/AIDS.It containsatazanavirandcobicistat.Atazanavir is anHIV protease inhibitorand cobicistat is an inhibitor ofcytochrome P450(CYP) enzymes of theCYP3Afamily. Atazanavir/cobicistat was approved by theFood and Drug Administration(FDA) for medical use in United States in January 2015.It was authorized for medical use in the European Union in July 2015.